Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00377065
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2016-04-22
First Post:
2006-09-14
Brief Title:
Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy 0518-023
Sponsor:
Organization:
Merck Sharp Dohme LLC